Engineered liposomes bearing camptothecin analogue for tumour targeting: in vitro and ex-vivo studies

References

• Abraham, S.A., et al., 2004. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. Journal of controlled release: official journal of the controlled release society, 96 (3), 449–461.
   PubMed Web of Science ®Google Scholar
• Abraham, S.A., et al., 2002. Formation of transition metal–doxorubicin complexes inside liposomes. Biochimica et Biophysica Acta (Bba) – Biomembranes, 1565 (1), 41–54.
   PubMed Web of Science ®Google Scholar
• Bishnoi, M., et al., 2020. Sublingual delivery of chondroitin sulfate conjugated tapentadol loaded nanovesicles for the treatment of osteoarthritis. Journal of liposome research, 1–33.doi:https://doi.org/10.1080/08982104.2020.1730400
   Google Scholar
• Blagosklonny, M.V., 2004. Analysis of FDA approved anticancer drugs reveals the future of cancer therapy. Cell cycle, 3 (8), 1033–1040.
   Web of Science ®Google Scholar
• Bolotin, E.M., et al., 1994. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes. Journal of liposome research, 4 (1), 455–479.
   Google Scholar
• Burke, T.G., and Gao, X., 1994. Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine. Journal of pharmaceutical sciences, 83 (7), 967–969.
   PubMed Web of Science ®Google Scholar
• Collins, D., Maxfield, F., and Huang, L., 1989. Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway. Biochimica et Biophysica Acta (Bba) – Biomembranes, 987 (1), 47–55.
   PubMedGoogle Scholar
• Connor, J., and Huang, L., 1986. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs. Cancer research, 46 (7), 3431–3435.
   PubMed Web of Science ®Google Scholar
• Cummings, R.D., and Smith, D.F., 1992. The selectin family of carbohydrate-binding proteins: structure and importance of carbohydrate ligands for cell adhesion. BioEssays: news and reviews in molecular, cellular and developmental biology, 14 (12), 849–856.
   PubMed Web of Science ®Google Scholar
• Danaei, M., et al., 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10 (2), 57.
   PubMed Web of Science ®Google Scholar
• Dennis, M. J., Beijnen, J. H., and Grochow, L. B., 1997. An overview of the clinical pharmacology of topotecaned.^eds. Seminars in oncology, 24 (1, Suppl 5), S5.
   Google Scholar
• Drummond, D.C., et al., 1999. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacological reviews, 51 (4), 691–743.
   PubMed Web of Science ®Google Scholar
• Drummond, D.C., et al., 2006. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer research, 66 (6), 3271–3277.
   PubMed Web of Science ®Google Scholar
• Fassberg, J., and Stella, V.J., 1992. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. Journal of pharmaceutical sciences, 81 (7), 676–684.
   PubMed Web of Science ®Google Scholar
• Fredman, P., Hedberg, K., and Brezicka, T., 2003. Gangliosides as therapeutic targets for cancer. BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy, 17 (3), 155–167.
   PubMed Web of Science ®Google Scholar
• Fry, D.W., White, J.C., and Goldman, I.D., 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Analytical biochemistry, 90 (2), 809–815.
   PubMed Web of Science ®Google Scholar
• Fugit, K.D., and Anderson, B.D., 2014. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan. Journal of controlled release: official journal of the controlled release society, 174, 88–97.
   PubMed Web of Science ®Google Scholar
• Gerasimov, O.V., et al., 1999. Cytosolic drug delivery using pH-and light-sensitive liposomes. Advanced drug delivery reviews, 38 (3), 317–338.
   PubMed Web of Science ®Google Scholar
• Greish, K., et al., 2003. Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. Clinical pharmacokinetics, 42 (13), 1089–1105.
   PubMed Web of Science ®Google Scholar
• Hao, Y.-L., et al., 2005a. In vitro and in vivo studies of different liposomes containing topotecan. Archives of pharmacal research, 28 (5), 626–635.
   PubMed Web of Science ®Google Scholar
• Hao, Y.L., et al., 2005b. In-vitro cytotoxicity, in-vivo biodistribution and anti-tumour effect of PEGylated liposomal topotecan. Journal of pharmacy and pharmacology, 57 (10), 1279–1287.
   PubMed Web of Science ®Google Scholar
• Haran, G., et al., 1993. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochimica et Biophysica Acta (BBA) – Biomembranes, 1151 (2), 201–215.
   PubMed Web of Science ®Google Scholar
• Hinrichs, W., et al., 2006. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. International journal of pharmaceutics, 311 (1–2), 237–244.
   PubMed Web of Science ®Google Scholar
• Hong, M.S., et al., 2002. pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system. The journal of pharmacy and pharmacology, 54 (1), 51–58.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2018. Ultrasound-based triggered drug delivery to tumors. Drug delivery and translational research, 8 (1), 150–164. doi:https://doi.org/10.1007/s13346-017-0448-6
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2020. Engineered nanosponges as versatile biodegradable carriers: An insight. Journal of drug delivery science and technology, 57, 101643. doi:https://doi.org/10.1016/j.jddst.2020.101643
   Web of Science ®Google Scholar
• Jain, A., et al., 2013. Dual drug delivery using “smart” liposomes for triggered release of anticancer agents. Journal of nanoparticle research, 15 (7), 1–12.
   Web of Science ®Google Scholar
• Jain, A., and Jain, S.K., 2015a. Ligand-appended BBB-targeted nanocarriers (LABTNs). Critical Reviews in therapeutic drug carrier systems, 32 (2), 149–180.
   PubMed Web of Science ®Google Scholar
• Jain, A., and Jain, S.K., 2015b. Colon Targeted Liposomal Systems (CTLS): Theranostic potential. Current molecular medicine, 15 (7), 621–633. doi:https://doi.org/10.2174/1566524015666150831131320
   PubMed Web of Science ®Google Scholar
• Jain, A., and Jain, S.K., 2016a. In vitro release kinetics model fitting of liposomes: an insight. Chemistry and physics of lipids., 201, 28–40.
   Web of Science ®Google Scholar
• Jain, A., and Jain, S.K., 2016b. Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer. Drug development and industrial pharmacy, 42 (1), 136–149.
   PubMed Web of Science ®Google Scholar
• Jain, S.K., and Jain, A., 2016c. Ligand mediated drug targeted liposomes. Liposomal delivery systems: advances and challenges, Future Medicine Ltd Unitec House 2 Albert Place London N3 1QB UK, 145.
   Google Scholar
• Jain, A., and Jain, S. K., 2017. Chapter 9: application potential of engineered liposomes in tumor targeting. In: A. Grumezescu (ed.) Multifunctional systems for combined delivery, biosensing and diagnostics. Elsevier – Health Sciences Division, 171–191.
   Google Scholar
• Jain, A., and Jain, S.K., 2018. Stimuli-responsive smart liposomes in cancer targeting. Current cancer drug targets, 19, 259–270.
   Google Scholar
• Jain, A., et al., 2018. Nanocarrier based advances in drug delivery to tumor: an overview. Current drug targets, 19 (13), 1498–1518.
   PubMed Web of Science ®Google Scholar
• Jain, A. J., and Sanjay, K., 2016. Liposomes in cancer therapy. In: J. Carlos (ed.) Nanocarrier systems for drug delivery. New York: Nova Science Publishers, 1–42.
   Google Scholar
• Jain, A., Hurkat, P., and Jain, S.K., 2019a. Development of liposomes using formulation by design: basics to recent advances. Chemistry and physics of lipids, 224, 104764.
   PubMed Web of Science ®Google Scholar
• Jain, A., et al., 2019b. Combination cancer therapy using multifunctional liposomes. Critical reviews in therapeutic drug carrier systems, 37 (2), 105–134.
   Web of Science ®Google Scholar
• Jayant, S., et al., 2007. Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment. Pharmaceutical Research, 24 (11), 2120–2130.
   PubMed Web of Science ®Google Scholar
• Karanth, H., and Murthy, R.S., 2007. pH-sensitive liposomes-principle and application in cancer therapy. The Journal of Pharmacy and Pharmacology, 59 (4), 469–483. Apr
   PubMed Web of Science ®Google Scholar
• Keepers, Y.P., et al., 1991. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. European journal of cancer and clinical oncology, 27 (7), 897–900.
   Google Scholar
• Kesharwani, P., et al., 2020. Systematic development and characterization of curcumin-loaded nanogel for topical application. Drug development and industrial pharmacy, 1–15. doi:https://doi.org/10.1080/03639045.2020.1793998
   Google Scholar
• Lee, R.J., and Low, P.S., 1995. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochimica et Biophysica Acta, 1233 (2), 134–144.
   PubMed Web of Science ®Google Scholar
• Li, L., Braiteh, F.S., and Kurzrock, R., 2005. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer, 104 (6), 1322–1331.
   PubMed Web of Science ®Google Scholar
• Li, C., et al., 2020. Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy. Biomaterials science, 8 (8), 2189–2201.
   PubMed Web of Science ®Google Scholar
• Liu, J.-J., et al., 2002. Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: stability, pharmacokinetic and therapeutic evaluation. Anti-cancer drugs, 13 (7), 709–717.
   PubMed Web of Science ®Google Scholar
• Mu, L., and Feng, S.-S., 2002. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). Journal of controlled release: official journal of the controlled release society, 80 (1–3), 129–144.
   PubMed Web of Science ®Google Scholar
• Ochi, M.M., et al., 2016. In vitro co-delivery evaluation of novel pegylated nano-liposomal herbal drugs of silibinin and glycyrrhizic acid (nano-phytosome) to hepatocellular carcinoma cells. Cell Journal, 18, 135.
   PubMed Web of Science ®Google Scholar
• Paliwal, S.R., et al., 2016. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin. Journal of liposome research, 26 (4), 276–287.
   PubMed Web of Science ®Google Scholar
• Perillo, N., Marcus, M.E., and Baum, L.G., 1998. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. Journal of molecular medicine, 76 (6), 402–412.
   PubMed Web of Science ®Google Scholar
• Plichta, A., et al., 2018. Effect of structural factors on release profiles of camptothecin from block copolymer conjugates with high load of drug. International journal of pharmaceutics, 538 (1–2), 231–242.
   PubMed Web of Science ®Google Scholar
• Rane, S., and Prabhakar, B., 2013. Optimization of paclitaxel containing pH-sensitive liposomes by 3 factor, 3 level box-behnken design. Indian journal of pharmaceutical sciences, 75 (4), 420–426.
   PubMed Web of Science ®Google Scholar
• Roux, E., et al., 2004. Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. Journal of controlled release: official journal of the controlled release society, 94 (2–3), 447–451.
   PubMed Web of Science ®Google Scholar
• Saraf, S., et al., 2016. Topotecan liposomes: a visit from a molecular to a therapeutic platform. Critical reviews in therapeutic drug carrier systems, 33 (5), 401–432.
   PubMed Web of Science ®Google Scholar
• Saraf, S., et al., 2020. Advances in liposomal drug delivery to cancer: an overview. Journal of drug delivery science and technology, 56, 101549.
   Web of Science ®Google Scholar
• Sharma, A., et al., 1995. Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice. Journal of pharmaceutical sciences, 84 (12), 1400–1404.
   PubMed Web of Science ®Google Scholar
• Sharma, V.K., Jain, A., and Soni, V., 2013. Nano-aggregates: emerging delivery tools for tumor therapy. Critical reviews in therapeutic drug carrier systems, 30 (6), 535–563.
   PubMed Web of Science ®Google Scholar
• She, Z., et al., 2014. The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate. Biomaterials, 35 (19), 5216–5225.
   PubMed Web of Science ®Google Scholar
• Shi, B., et al., 2014. Endosomal pH responsive polymers for efficient cancer targeted gene therapy. Colloids and surfaces. b, biointerfaces, 119, 55–65.
   PubMed Web of Science ®Google Scholar
• Skehan, P., et al., 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the national cancer institute, 82 (13), 1107–1112.
   PubMed Web of Science ®Google Scholar
• Subramanian, D., and Muller, M.T., 1995. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan. Oncology research, 7 (9), 461–469.
   PubMed Web of Science ®Google Scholar
• Taggar, A.S., et al., 2006. Copper-topotecan complexation mediates drug accumulation into liposomes. Journal of controlled release: official journal of the controlled release society, 114 (1), 78–88.
   PubMed Web of Science ®Google Scholar
• Tardi, P., et al., 2000. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models. Cancer research, 60 (13), 3389–3393.
   PubMed Web of Science ®Google Scholar
• Tiwari, A., et al., 2020. Basics to advances in nanotherapy of colorectal cancer. Drug delivery and translational research, 10 (2), 319–338. doi:https://doi.org/10.1007/s13346-019-00680-9
   PubMed Web of Science ®Google Scholar
• Underberg, W., et al., 1990. Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution. Journal of pharmaceutical and biomedical analysis, 8 (8–12), 681–683.
   PubMed Web of Science ®Google Scholar
• Verma, A., et al., 2019. Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): a preclinical investigation. International journal of biological macromolecules, 133, 1142–1155.
   PubMed Web of Science ®Google Scholar
• Vichai, V., and Kirtikara, K., 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature protocols, 1 (3), 1112–1116.
   PubMed Web of Science ®Google Scholar
• Wang, C.Y., and Huang, L., 1989. Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry, 28 (24), 9508–9514.
   PubMed Web of Science ®Google Scholar
• Wang, N., et al., 2009. Modulation of the physicochemical state of interior agents to prepare controlled release liposomes. Colloids and surfaces. B, biointerfaces, 69 (2), 232–238.
   PubMed Web of Science ®Google Scholar
• Wei, Y., et al., 2014. Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes. International journal of nanomedicine, 9, 3623–3630.
   PubMed Web of Science ®Google Scholar
• Wei, H., et al., 2013. Active loading liposomal irinotecan hydrochloride: preparation, in vitro and in vivo evaluation. Asian journal of pharmaceutical sciences, 8 (5), 303–311.
   Google Scholar
• Yang, Y., Ma, Y., and Wang, S., 2012. A novel method to load topotecan into liposomes driven by a transmembrane NH4EDTA gradient. European journal of pharmaceutics and biopharmaceutics, 80 (2), 332–339.
   PubMed Web of Science ®Google Scholar
• Yousefi, A., et al., 2009. Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel. Scientia pharmaceutica, 77 (2), 453–464.
   Google Scholar
• Zhou, S., et al., 2017. Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity. International journal of pharmaceutics, 523 (1), 203–216.
   PubMed Web of Science ®Google Scholar